The medical landscape for glucose is evolving, and transdermal GLP-1 delivery systems represent a exciting breakthrough. Unlike subcutaneous injections, this approach offers a less invasive way to administer GLP-1 drugs. These transdermal systems gradually release the drug through the epidermis offe